Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael W Graner

Showing results (1-10 of 76) with videos related to

Pageof 8
Sort By:
Seminars in Immunopathology|September 14, 2018
Extracellular vesicles in cancer immune responses: roles of purinergic receptorsMichael W Graner
Annual Review of Genomics and Human Genetics|April 13, 2019
Roles of Extracellular Vesicles in High-Grade Gliomas: Tiny Particles with Outsized InfluenceMichael W Graner
Advances in Cancer Research|February 27, 2016
HSP90 and Immune Modulation in CancerMichael W Graner
Cell Chemical Biology|February 19, 2021
Making HSP90 Inhibitors Great Again? Unite for Better Cancer ImmunotherapyMichael W Graner
Future Science OA|December 30, 2016
The unfolded protein response in glioblastomas: targetable or trouble?Michael W Graner
Neuro-Oncology|August 2, 2005
Chaperone proteins and brain tumors: potential targets and possible therapeuticsMichael W Graner, Darell D Bigner
Vaccines|December 24, 2015
The Dichotomy of Tumor Exosomes (TEX) in Cancer Immunity: Is It All in the ConTEXt?Katherine E Kunigelis, Michael W Graner
Expert Review of Anticancer Therapy|June 9, 2006
Therapeutic aspects of chaperones/heat-shock proteins in neuro-oncologyMichael W Graner, Darell D Bigner
Cancer Immunology, Immunotherapy : CII|May 12, 2005
Chaperone-rich cell lysates, immune activation and tumor vaccinationYi Zeng, Michael W Graner, Emmanuel Katsanis
International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group|June 4, 2013
The 'peptidome' of tumour-derived chaperone-rich cell lysate anti-cancer vaccines reveals potential tumour antigens that stimulate tumour immunityMichael W Graner, Angela Romanoski, Emmanuel Katsanis
Pageof 8

Showing results (1-10 of 76) with videos related to

Sort By:
Pageof 8
Seminars in Immunopathology|September 14, 2018
Extracellular vesicles in cancer immune responses: roles of purinergic receptorsMichael W Graner
Annual Review of Genomics and Human Genetics|April 13, 2019
Roles of Extracellular Vesicles in High-Grade Gliomas: Tiny Particles with Outsized InfluenceMichael W Graner
Advances in Cancer Research|February 27, 2016
HSP90 and Immune Modulation in CancerMichael W Graner
Cell Chemical Biology|February 19, 2021
Making HSP90 Inhibitors Great Again? Unite for Better Cancer ImmunotherapyMichael W Graner
Future Science OA|December 30, 2016
The unfolded protein response in glioblastomas: targetable or trouble?Michael W Graner
Neuro-Oncology|August 2, 2005
Chaperone proteins and brain tumors: potential targets and possible therapeuticsMichael W Graner, Darell D Bigner
Vaccines|December 24, 2015
The Dichotomy of Tumor Exosomes (TEX) in Cancer Immunity: Is It All in the ConTEXt?Katherine E Kunigelis, Michael W Graner
Expert Review of Anticancer Therapy|June 9, 2006
Therapeutic aspects of chaperones/heat-shock proteins in neuro-oncologyMichael W Graner, Darell D Bigner
Cancer Immunology, Immunotherapy : CII|May 12, 2005
Chaperone-rich cell lysates, immune activation and tumor vaccinationYi Zeng, Michael W Graner, Emmanuel Katsanis
International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group|June 4, 2013
The 'peptidome' of tumour-derived chaperone-rich cell lysate anti-cancer vaccines reveals potential tumour antigens that stimulate tumour immunityMichael W Graner, Angela Romanoski, Emmanuel Katsanis
Pageof 8